InSilicoTrials Releases Two New State-of-the-Art Simulation Tools for Oncology

News · PharmaMirror

InSilicoTrials launches two new oncology simulation modules, enabling pharmaceutical researchers to model tumour response and chemotherapy toxicity profiles in virtual patient populations.